Ethyl 2-(3-(2-((3-fluorophenyl)amino)-2-oxoethyl)-4-oxothiazolidin-2-ylidene)acetate, 98%, 250mg

1,3,4,6-Tetrakis(hydroxymethyl)tetrahydroimidazo[4,5-d]imidazole-2,5(1H,3H)-dione>95.0%(GC)(qNMR)25g

Ethyl 3-Bromoimidazo[1,2-a]pyrimidine-2-carboxylate, 97.0%, 1g

7-Methylene-2-oxaspiro[3.5]nonane, 1g

(1R,3S,E)-5-((E)-2-((1R,3aS,7aR)-1-((2R,5S,E)-5-Cyclopropyl-5-hydroxypent-3-en-2-yl)-7a-methylhexahydro-1H-inden-4(2H)-ylidene)ethylidene)-4-methylenecyclohexane-1,3-diol, 98%, 5g

Methyl5-bromo-2-chloropyrimidine-4-carboxylate, 98+%, 250mg

4-Bromo-3-chloro-2,5-difluorobenzoic acid, 98%, 1g

4-amino-6-fluoro-3-quinolinecarboxylic acid, 95.0%, 1g

5-Methylpyridine-2-carboxylic acid, 97.0%, 1g

5-BROMO-4-CHLOROISOQUINOLINE, 95.0%, 500mg

2-(Cyclohexyloxy)benzoic acid, 95%, 500mg

Dimethyl 3-nitrophthalate, 98.0%, 100g

3-Chloro-pyrazine-2-carboxylic acid ethyl ester, 95.0%, 250mg